SEPT 2019 - Following attendance at the Veterinary Medical Conference, Myrtle Beach SC in August 2019, Test&Treat gained 5 new customers in the US veterinary market.
Test&Treat is in early stage discussions with a Chinese medical company to license the AS technology, prospectively, for the Chinese diagnostics marketplace.
Test&Treat has successfully registered 'U-test' as a working brand.
NOV 2018 - Test&Treat is pleased to announce that the PCT submission “Rapid Determination of Bacterial Susceptibility to an Antibiotic at the Point of Care” (Application No. 15/305550) was granted by the United States Patent and Trademark Office (USPTO) on November 20th 2018”
OCT 2018 - Test & Treat has entered a lease agreement for premises on Lanwades Business Park, Kentford, Newmarket UK to be used to manufacture diagnostic reagents.
AUG 2018 - The following patent, filed as a PCT (04/20/2015) in USA, Canada and Europe was allowed by the USPTO (15/305,550; filing date 10/20/2016; Inventor: Ronald Turner) in August 2018 and is expected to be granted by December 2018
This relates to the technology utilised to produce the point of care tests being commercialised as an aid to detection and management (Antibiotic Susceptibility) of Urinary Tract Infection (UTI)